iZafe Group AB (publ), a medical technology company, develops and markets medical and digital security solutions in Sweden and internationally. It offers Dosell, an automated medication dispenser for medication at home; and Pilloxa, an app for clinical studies, as well as to engage and involve patients. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does iZafe Group AB Series B (IZAFE-B) operate in?
iZafe Group AB Series B belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is iZafe Group AB Series B (IZAFE-B) current stock price?
As of the latest data, iZafe Group AB Series B stock price is SEK 0.31, with a previous close of SEK 0.32. iZafe Group AB Series B lost -SEK 0.01 in the last trading session, representing a -1.57% loss.
What is iZafe Group AB Series B (IZAFE-B) current market capitalization?
iZafe Group AB Series B market cap is approximately 127.48 million.
What is iZafe Group AB Series B (IZAFE-B) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.06.
What is iZafe Group AB Series B (IZAFE-B) EBITDA?
iZafe Group AB Series B EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -4.31 million.
Does iZafe Group AB Series B (IZAFE-B) pay dividends?
No. iZafe Group AB Series B does not pay a dividend.
What is iZafe Group AB Series B (IZAFE-B) beta (volatility) score?
iZafe Group AB Series B has a beta of -0.010, indicating lower volatility than the overall market.
